- Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
-
Teng PC, Huang DQ, Lin TY, Noureddin M, Yang JD
- KMID: 2538154
- Gut Liver.
- 2023 Jan;17(1):24-33.
- doi: 10.5009/gnl220357
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world. NAFLD is a hepatic manifestation of insulin resistance, the core pathophysiology of diabetes.... -
- CITED
-
- Close
- SHARE
-
- Close
- Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
-
Sohn W, Paik YH
- KMID: 2538220
- Clin Mol Hepatol.
- 2023 Jan;29(1):182-184.
- doi: 10.3350/cmh.2022.0411
-
- CITED
-
- Close
- SHARE
-
- Close
- Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
-
Lee SM, Jun DW
- KMID: 2538216
- Clin Mol Hepatol.
- 2023 Jan;29(1):171-172.
- doi: 10.3350/cmh.2022.0381
-
- CITED
-
- Close
- SHARE
-
- Close
- The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
-
Cho Y, Kim BH, Park JW
- KMID: 2538203
- Clin Mol Hepatol.
- 2023 Jan;29(1):99-101.
- doi: 10.3350/cmh.2022.0321
-
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
-
Chon YE, Park SY, Hong HP, Son D, Lee J, Yoon E, Kim SS, Ahn SB, Jeong SW, Jun DW
- KMID: 2538209
- Clin Mol Hepatol.
- 2023 Jan;29(1):120-134.
- doi: 10.3350/cmh.2021.0395
Background/Aims: A comprehensive analysis of trends in the incidence of hepatocellular carcinoma (HCC) is important for planning public health initiatives. We aimed to analyze the trends in HCC incidence in... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment
-
Park SJ, Hahn YS
- KMID: 2538201
- Clin Mol Hepatol.
- 2023 Jan;29(1):65-76.
- doi: 10.3350/cmh.2022.0032
Hepatitis C virus (HCV) infection is remarkably efficient in establishing viral persistence, leading to the development of liver cirrhosis and hepatocellular carcinoma (HCC). Direct-acting antiviral agents (DAAs) are promising HCV... -
- CITED
-
- Close
- SHARE
-
- Close
- Development and prognosis of hepatocellular carcinoma in patients with diabetes
-
Nakatsuka T, Tateishi R
- KMID: 2538200
- Clin Mol Hepatol.
- 2023 Jan;29(1):51-64.
- doi: 10.3350/cmh.2022.0095
The incidence of diabetes mellitus and hepatocellular carcinoma (HCC) has been increasing worldwide during the last few decades, in the context of an increasing prevalence of obesity and non-alcoholic fatty... -
- CITED
-
- Close
- SHARE
-
- Close
- Wnt signaling in liver regeneration, disease, and cancer
-
Zou G, Park JI
- KMID: 2538199
- Clin Mol Hepatol.
- 2023 Jan;29(1):33-50.
- doi: 10.3350/cmh.2022.0058
The liver exhibits the highest recovery rate from acute injuries. However, in chronic liver disease, the long-term loss of hepatocytes often leads to adverse consequences such as fibrosis, cirrhosis, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Percutaneous radiofrequency ablation of hepatocellular carcinoma in a recent cohort at a tertiary cancer center: incidence and factors associated with major complications and unexpected hospitalization events
-
Jo MG, Lee MW, Ahn S, Kang TW, Song KD, Cha DI, Min JH, Rhim H
- KMID: 2537420
- Ultrasonography.
- 2023 Jan;42(1):41-53.
- doi: 10.14366/usg.22041
Purpose: This study aimed to assess the incidence of and factors associated with major complications, delayed discharge, and emergency room (ER) visits or readmission after percutaneous radiofrequency ablation (RFA) for... -
- CITED
-
- Close
- SHARE
-
- Close
- Metastatic breast cancer from a hepatocellular carcinoma: a case report
-
Bang H, Kim NH, Choi SH, Bae SH, Jung ES, Min KO, Eom YH
- KMID: 2538065
- Korean J Clin Oncol.
- 2022 Dec;18(2):93-96.
- doi: 10.14216/kjco.22013
Breast metastases from extramammary malignancies are rare. Here, we report a case of breast metastasis from hepatocellular carcinoma (HCC) after breast mass excision in a 63-year-old woman. A new breast... -
- CITED
-
- Close
- SHARE
-
- Close
- 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
-
Park JW
- KMID: 2536340
- Korean J Radiol.
- 2022 Dec;23(12):1126-1240.
- doi: 10.3348/kjr.2022.0822
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth most common cancer among men in South Korea, where the prevalence of chronic hepatitis B infection is... -
- CITED
-
- Close
- SHARE
-
- Close
- Involvement of adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 in diallyl trisulfide-induced cytotoxicity in hepatocellular carcinoma cells
-
Guan F, Ding Y, He Y, Li L, Yang X, Wang C, Hu M
- KMID: 2534522
- Korean J Physiol Pharmacol.
- 2022 Nov;26(6):457-468.
- doi: 10.4196/kjpp.2022.26.6.457
It has been demonstrated that APPL1 (adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1) is involved in the regulation of several growth-related signaling pathways and thus closely... -
- CITED
-
- Close
- SHARE
-
- Close
- SonazoidTM versus SonoVue® for Diagnosing Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound in At-Risk Individuals: A Prospective, Single-Center, Intraindividual, Noninferiority Study
-
Kang HJ, Lee JM, Yoon JH, Yoo J, Choi Y, Joo I, Han JK
- KMID: 2534419
- Korean J Radiol.
- 2022 Nov;23(11):1067-1077.
- doi: 10.3348/kjr.2022.0388
Objective: To determine whether Sonazoid-enhanced ultrasound (SZUS) was noninferior to SonoVue-enhanced ultrasound (SVUS) in diagnosing hepatocellular carcinoma (HCC) using the same diagnostic criteria. Materials and Methods: This prospective, single-center, noninferiority study... -
- CITED
-
- Close
- SHARE
-
- Close
- Spinal Cord Infarction After Transarterial Chemoembolization for Hepatocellular Carcinoma
-
Lee SG, Cho SM, Whang K, Jang Yg, Kim J, Choi J
- KMID: 2538480
- Korean J Neurotrauma.
- 2022 Oct;18(2):404-409.
- doi: 10.13004/kjnt.2022.18.e65
Transarterial chemoembolization (TACE) is an effective treatment for unresectable hepatocellular carcinoma (HCC). It is considered relatively safe. However, fatal complications such as pulmonary edema and liver abscesses can occur. Spinal... -
- CITED
-
- Close
- SHARE
-
- Close
- 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
-
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea
- KMID: 2534337
- Clin Mol Hepatol.
- 2022 Oct;28(4):583-705.
- doi: 10.3350/cmh.2022.0294
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth most common cancer among men in South Korea, where the prevalence of chronic hepatitis B infection is... -
- CITED
-
- Close
- SHARE
-
- Close
- Surveillance for hepatocellular carcinoma: It is time to move forward
-
Kim BH, Cho Y, Park JW
- KMID: 2534346
- Clin Mol Hepatol.
- 2022 Oct;28(4):810-813.
- doi: 10.3350/cmh.2022.0257
-
- CITED
-
- Close
- SHARE
-
- Close
- Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases
-
Shin HS, Jun BG, Yi SW
- KMID: 2534342
- Clin Mol Hepatol.
- 2022 Oct;28(4):773-789.
- doi: 10.3350/cmh.2021.0383
Despite the increasing prevalence of metabolic disorders, the potential effects of metabolic factors on hepatocellular carcinoma (HCC) development in individuals with chronic liver diseases (CLDs) are not well understood. For... -
- CITED
-
- Close
- SHARE
-
- Close
- Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis
-
Tan DJH, Quek SXZ, Yong JN, Suresh A, Koh KXM, Lim WH, Quek J, Tang A, Tan C, Nah B, Tan E, Keitoku T, Muthiah MD, Syn N, Ng CH, Kim BK, Tamaki N, Ho CSH, Loomba R, Huang DQ
- KMID: 2534351
- Clin Mol Hepatol.
- 2022 Oct;28(4):864-875.
- doi: 10.3350/cmh.2022.0136
Background/Aims: Depression and anxiety are associated with poorer outcomes in patients with hepatocellular carcinoma (HCC). However, the prevalence of depression and anxiety in HCC are unclear. We aimed to establish... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease
-
Sohn W, Kang D, Kang M, Guallar E, Cho J, Paik YH
- KMID: 2534350
- Clin Mol Hepatol.
- 2022 Oct;28(4):851-863.
- doi: 10.3350/cmh.2022.0037
Background/Aims: This study aimed to investigate the effect of hepatocellular carcinoma (HCC) surveillance using the Korea National Liver Cancer Screening Program on the receipt of curative treatment for HCC and... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review
-
Kim SJ, Kim JM
- KMID: 2534340
- Clin Mol Hepatol.
- 2022 Oct;28(4):739-753.
- doi: 10.3350/cmh.2022.0060
Liver transplantation (LT) is one of the most effective treatments for hepatocellular carcinoma (HCC). Although LT eliminates HCC and greatly reduces recurrence, some patients experience recurrence after LT. Criteria and... -
- CITED
-
- Close
- SHARE
-
- Close
